Status:
COMPLETED
Physical Therapy and Cognitive Decline
Lead Sponsor:
IRCCS National Neurological Institute "C. Mondino" Foundation
Conditions:
Parkinson Disease
Cognitive Impairment
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
Background: Mild Cognitive Impairment in Parkinson's disease (PD-MCI) is considered a predictor for the development of dementia, a major source of eventual treatment-refractory disability. Physical ac...
Detailed Description
Non-pharmacological intervention may represent adjunctive therapy to medications in order to delay the onset of the cognitive deficits or dementia. Previous studies observed a positive effect of cogn...
Eligibility Criteria
Inclusion
- diagnosis of idiopathic PD according to UKPDBB criteria 26 and Hoehn \& Yahr scale ≤3;
- presence of PD-MCI single- or multiple-domain;
- age between 50 and 85 years;
- educational level ≥ 5 years.
Exclusion
- pre-existing cognitive impairment (e.g. aphasia, neglect);
- severe disturbances in consciousness;
- concomitant severe psychiatric disease or others neurological conditions (e.g. depression and behavioural disorders).
Key Trial Info
Start Date :
September 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04012086
Start Date
September 15 2015
End Date
March 15 2018
Last Update
July 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Mondino Foundation
Pavia, Italy, 27100